Compositional brain scores capture Alzheimer's disease-specific structural brain patterns along the disease continuum
Por:
Genius, P, Calle, ML, Rodríguez-Fernández, B, Minguillon, C, Cacciaglia, R, Garrido-Martin, D, Esteller, M, Navarro, A, Gispert, JD, Vilor-Tejedor, N, Alzheimers Dis Neuroimaging Initiat and ALFA study
Publicada:
1 feb 2025
Ahead of Print:
1 ene 2025
Resumen:
INTRODUCTION: Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum. METHODS: This study analyzed data from participants across the AD continuum from the Alzheimer's and Families (ALFA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Compositional data analysis (CoDA) was exploited to examine relative brain volumetric variations that (1) were linked to different AD stages compared to cognitively unimpaired amyloid-beta-negative (CU A-) individuals and (2) varied by AD genetic risk. RESULTS: Disease stage-specific compositional brain scores were identified, differentiating CU A- individuals from those in more advanced stages. Genetic risk-stratified models revealed a broader genetic landscape affecting brain morphology in AD, beyond the well-known apolipoprotein E epsilon 4 allele. DISCUSSION: CoDA emerges as an alternative multivariate framework to deepen understanding of AD-related structural changes and support targeted interventions for those at higher genetic risk. Highlights Compositional data analysis (CoDA) revealed the relative variation of brain region volumes, captured in compositional brain scores, capable of discerning between cognitively unimpaired amyloid-beta-negative individuals and subjects within other disease-stage groups along the Alzheimer's disease (AD) continuum. CoDA also uncovered the genetic vulnerability of specific brain regions at each stage of the disease along the continuum. CoDA is capable of integrating magnetic resonance imaging data from two different cohorts without stringent requirements for harmonization. This translates as an advantage, compared to traditional methods, and strengthens the reliability of cross-study comparisons by standardizing the data despite different labeling agreements, facilitating collaborative and large-scale research. The algorithm is sensitive to AD-specific effects, as the main compositional brain scores display little overlap with the age-specific compositional brain score. CoDA provides a more accurate analysis of brain imaging data addressing its compositional nature, which can influence the development of targeted approaches, opening new avenues for enhancing brain health.
Filiaciones:
Genius, P:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain
Univ Vic Cent Univ Catalonia UV UCC, Doctoral Sch, PhD programme Bioinformat, Vic, Spain
Calle, ML:
Univ Vic Cent Univ Catalonia, Fac Sci Technol & Engn, Biosci Dept, Vic, Spain
Rodríguez-Fernández, B:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain
Minguillon, C:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Inst Salud Carlos III, Ctr Invest Biomed Red Fragil & Envejecimiento Salu, Madrid, Spain
Cacciaglia, R:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Inst Salud Carlos III, Ctr Invest Biomed Red Fragil & Envejecimiento Salu, Madrid, Spain
Garrido-Martin, D:
Univ Barcelona UB, Dept Genet Microbiol & Stat, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Ctra Can Ruti,Cami Escoles,, Barcelona, Spain
Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
Univ Barcelona UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Navarro, A:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain
Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
Pompeu Fabra Univ, Barcelona, Spain
Univ Pompeu Fabra, Inst Evolutionary Biol CSIC UPF, Dept Expt & Hlth Sci, Barcelona, Spain
Gispert, JD:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Inst Salud Carlos III, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid, Spain
Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain
Vilor-Tejedor, N:
Barcelonasseta Brain Res Ctr BBRC, Pasqual Maragall Fdn, C Wellington 30, Barcelona 08005, Spain
Hosp Mar Res Inst, Barcelona, Spain
Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain
Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
Green Submitted, Green Accepted, hybrid
|